Feed aggregator

Report: When It Comes to Hiring PhDs, Private Sector and Academia Are About Even

Biospace news - 20 hours 2 min ago
For years, the biggest employers of science and engineering PhDs has been academic institutions. For example, according to the U.S. National Science Foundation (NSF)’s biennial Survey of Doctoral Recipients, academia employed 11 percent more PhDs than the private sector in 1997.

National Kidney Month: A Look at Biopharma's Progress in Kidney Diseases

Biospace news - 20 hours 2 min ago
March is National Kidney Month, with March 14 designated as World Kidney Day. The kidneys are called the body’s chemical factories. Their job is to filter waste and perform specific important jobs like controlling red blood cell production and blood pressure.

California Life Sciences Association Names Three Life Science Champions

Biospace news - 20 hours 2 min ago
The life sciences industry is incredibly important to the financial ecosystem of the Golden State. Last year the industry generated total annual revenue of $177.1 billion in the state.

Merck to collaborate with GenScript to accelerate cell and gene therapy industrialization in China

World Pharma News - Tue, 03/19/2019 - 13:00
Merck, a leading science and technology company, today announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing.

Go for a run or eat chocolate: A choice dictated by the cannabinoid receptors

World Pharma News - Tue, 03/19/2019 - 11:00
Physical inactivity is a common factor in lifestyle diseases - and one that is often linked to the excessive consumption of fatty and/or sugary foods. The opposite scenario of excessive physical activity at the expense of caloric intake can also be harmful, as cases of anorexia nervosa illustrate. These data therefore point to the crucial need to research the neurobiological processes that control the respective motivations for exercise and food intake.

Genentech’s Tecentriq Wins Approval for ES-SCLC, Its Second of the Month

Biospace news - Tue, 03/19/2019 - 02:00
This approval marks the first new initial treatment option for this difficult-to-treat type of lung cancer in more than 20 years.

Amarin’s Vascepa Cuts Heart Attack and Stroke Risk by 30%

Biospace news - Tue, 03/19/2019 - 02:00
“With this drug, we are not only preventing that first heart attack, but potentially the second stroke and maybe that third fatal event,” stated Deepak Bhatt, the study’s lead investigator.

Women's History Month: Top Influential Women in Biopharma

Biospace news - Tue, 03/19/2019 - 02:00
March is National Women’s Month with March 8 specifically designated as International Women’s Day. Although this is not remotely a comprehensive list, BioSpace recognizes these 10 women (in no particular order) as being especially influential in the biopharma industry.

Starboard, Opposed to BMS Deal for Celgene, Readies for Fight at April Meeting

Biospace news - Tue, 03/19/2019 - 02:00
This morning Starboard Value LP issued an investor presentation opposing the proposed deal. The group will share the materials with other shareholders in hopes to sway support for its opposition.

FDA Places Partial Clinical Hold on AbbVie’s Venclexta-Based Multiple Myeloma Trial

Biospace news - Tue, 03/19/2019 - 02:00
In a Phase III trial, a higher proportion of deaths was observed in the venetoclax arm compared to the control arm of the trial.

Vivek Ramaswamy's Urovant Headed to FDA With Vibegron After Positive Phase III Data

Biospace news - Tue, 03/19/2019 - 02:00
The company announced positive topline results from its Phase III EMPOWUR trial of viregron in patients with overactive bladder.

Esperion’s Cholesterol Drug Looks Great in Phase III, but Faces Tough Market

Biospace news - Tue, 03/19/2019 - 02:00
Esperion, based in Ann Arbor, Mich., announced results from its Phase III Study 2 of bempedoic acid at the American College of Cardiology (ACC) annual meeting.

Sanofi Eyes Its Next CEO as Olivier Brandicourt Nears the End of His Term

Biospace news - Tue, 03/19/2019 - 02:00
The French company has an age limit for its top official and the company is working on a succession plan in anticipation of that change.

Allergy Therapeutics’ Birch Allergy Jab Has a Puzzling Failure

Biospace news - Tue, 03/19/2019 - 02:00
UK-based Allergy Therapeutics markets three allergy “jabs” for tree pollen, dust mites, and grass pollen. Later this year it is planning results from a Phase I trial of a dust mite vaccine. But the company’s results from its trial for a birch pollen vaccine are a bit puzzling—the vaccine flunked ...

Allergan's NDA for Migraine Med With Novel Mechanism of Action Accepted by FDA

Biospace news - Tue, 03/19/2019 - 02:00
Allergan, which has been a leader in the migraine space, hopes to have a new treatment available for patients using a new mechanism of action for acute treatment of migraine.

US FDA grants saracatinib Orphan Drug Designation for idiopathic pulmonary fibrosis

World Pharma News - Mon, 03/18/2019 - 13:00
The US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for saracatinib, a potential new medicine for the treatment of idiopathic pulmonary fibrosis (IPF), a type of lung disease that results in scarring (fibrosis) of the lungs. Saracatinib is an inhibitor of src kinase which regulates broad cell functions including cell growth and cell differentiation.

Diabetes drug effective against heart failure in wide spectrum of patients

World Pharma News - Mon, 03/18/2019 - 11:00
The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with reduced ejection fraction, a measure of the heart's pumping ability indicative of poor heart functioning, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Apple Watch Atrial Fibrillation Study Has High Rate of False Positives

Biospace news - Mon, 03/18/2019 - 02:00
Stanford University researchers kicked off the annual meeting of the American College of Cardiology (ACC) with a very large study of more than 400,000 patients in a trial sponsored by Apple.

Is It Alzheimer's or Some Other Type of Dementia? The Diagnosis Matters.

Biospace news - Mon, 03/18/2019 - 02:00
Within the non-medical community, there is a tendency to just refer to dementia and Alzheimer’s interchangeably, but the Alzheimer’s Disease-Related Dementias Summit 2019 emphasized that physicians need to make the distinction for best patient care.

ACC Roundup: Less Aspirin to Prevent Heart Attacks, Bristol-Myers & Pfizer, Apple Watch and More

Biospace news - Mon, 03/18/2019 - 02:00
The American College of Cardiology (ACC) annual meeting was held this weekend in New Orleans. Here’s a look at some of the top stories that came out of the meeting.